[Form 4] UL Solutions Inc. Insider Trading Activity

Rhea-AI Filing Summary

James P. Dollive, a director of UL Solutions Inc. (ULS), reported an equity grant accrual on 09/08/2025 that increased his beneficial ownership. The filing shows the accrual of 5 dividend equivalent rights tied to restricted stock units, each right representing one share of Class A common stock, recorded at a $0 price. After the reported accrual, the reporting person beneficially owned 2,797 shares (including outstanding restricted stock units and accrued dividend equivalents). The restricted stock units (and their dividend equivalents) vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/10/2025.

Positive

• Accrual of dividend-equivalent rights documented transparently, increasing beneficial ownership to 2,797 shares
• Vesting terms disclosed (earlier of May 20, 2026 or the next annual meeting), clarifying timing of potential share delivery
• Timely filing (signed on 09/10/2025) demonstrating compliance with Section 16 reporting

Negative

• None.

Insights

Financial Analyst

TL;DR: Director accrued 5 dividend-equivalent rights, bringing beneficial ownership to 2,797 shares; transaction is routine and immaterial to valuation.

The reported transaction is an accrual of dividend equivalent rights on existing restricted stock units rather than an open-market purchase or sale. The 5 accrued rights, recorded at $0, are small in absolute terms versus the company's outstanding float and do not alter control or materially affect capitalization. Vesting is tied to existing RSU schedules, with an earlier vest date of May 20, 2026 or the next annual meeting, indicating these are part of standard compensation practices for insiders.

Corporate Governance Expert

TL;DR: Transaction reflects standard executive compensation mechanics; disclosure is timely and consistent with Section 16 reporting requirements.

This Form 4 documents the accrual of dividend equivalents on restricted stock units held by a director. The filing discloses the nature, amount, and vesting condition clearly and was submitted within normal reporting windows. There are no indications of atypical timing, related-party transfers, or deviation from typical equity award terms in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DOLLIVE JAMES P

(Last) (First) (Middle)

C/O UL SOLUTIONS INC.

333 PFINGSTEN ROAD

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	09/08/2025		A		5(2)		(3)	(3)	Class A Common Stock	5	$0	2,797(4)	D

Explanation of Responses:

1. Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.

2. Represents accrual of dividend equivalent rights on restricted stock units held by the Reporting Person.

3. The dividend equivalent rights accrued on restricted stock units held by the Reporting Person and vest proportionately with the restricted stock units to which they relate. The restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date.

4. Includes restricted stock units and all dividend equivalent rights that have accrued on such restricted stock units to date.

	/s/ Ryan Robinson, Attorney-in-Fact	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did James P. Dollive report on the Form 4 for ULS?

He reported the accrual of 5 dividend equivalent rights on restricted stock units, representing 5 underlying shares, on 09/08/2025.

How many shares does the reporting person beneficially own after the transaction?

The filing shows beneficial ownership of 2,797 shares following the reported accrual.

When do the restricted stock units and dividend equivalents vest?

They vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date.

Was there any purchase price for the accrued dividend equivalents?

No purchase price was reported; the transaction is shown with a $0 price, reflecting accrual of dividend equivalents.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by Ryan Robinson, Attorney-in-Fact on 09/10/2025.

Does this Form 4 indicate a material change to UL Solutions' capitalization or control?

No. The accrual of 5 dividend equivalents is routine compensation-related activity and is not material to company capitalization or control.